SEEGRAF 1MG CAPSULE

Tacrolimus, the active ingredient in Ringraf 1mg Capsule, is a calcineurin inhibitor that plays a crucial role in immunosuppression. Alongside other medications, it is used to avert organ transplant rejection in individuals who have undergone liver, kidney, heart, or different types of transplant surgeries. By modulating the body’s immune response, Tacrolimus helps the body accept the transplanted organ, ensuring a successful transplant outcome. If you are allergic to Tacrolimus or any other component of this medication, do not take the Ringraf 1mg Capsule. Also, inform your doctor if you are allergic to any other antibiotic group. Before starting treatment, let your doctor know if you have a liver or heart disease history. Immediately notify your physician if you experience fever, subcutaneous bruising (which may appear as red dots), unexplained fatigue, confusion, jaundice, reduced urine output, vision loss, or seizures after taking this medication. When taking Ringraf 1mg Capsule, minimize exposure to direct sunlight and UV radiation by wearing protective clothing and applying sunscreen with a high SPF. This is due to the possible risk of skin cancer associated with immunosuppressive therapy. Additionally, this medication may cause diarrhea, so inform your doctor if it persists for more than a day. If you need to receive any vaccinations, consult with your physician beforehand.